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Many areas of research today are based on enzymatic assays most of which are still performed as
enzyme-linked immunosorbent assays in microtiter plates. The demand for highly parallel
screening of thousands of samples eventually led to a miniaturization and automation of these
assays. However, the final transfer of enzymatic assays from a microtiter-based technology to
microarrays has proven to be difficult for various reasons, such as the inability to maintain
unbound reaction products on the spot of reaction or the missing capability of multiplexing.
Here, we have conducted multiplex enzymatic assays in subnanoliter volumes on a single
microarray using the multiple spotting technology. We were able to measure enzymatic activity
with a sensitivity down to 35 enzyme molecules, applying only conventional flat microarray sur-
faces and standard microarray hardware. We have performed assays of inhibition and applied
this format for the detection of prognostic markers, such as cathepsin D. The new approach
allows the rapid and multiplex screening of thousands of samples on a single microarray with
applications in drug screening, metagenomics, and high-throughput enzyme assays.
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1 Introduction
The investigation of enzymatic reactivity is an important part
of current proteomics research, with diverse areas of appli-
cation, such as the identification and localization of enzymes
within the cellular network, screening of drug candidates,
development of diagnostic assays as well as optimization of
enzymatic function through mutagenesis. Since many of
these applications require high-throughput analysis with
minimal consumption of the precious samples, the transfer
of such assays to microarrays is desirable [1]. Several investi-
gations regarding the transfer of enzymatic assays to nano-
wells and microarrays have been performed, which pre-
dominantly describe the enzymatic phosphorylation of pep-
tides and proteins by kinases [2–5]. Additionally, cell-free
expression and analysis of green fluorescent protein and b-
galactosidase (b-gal) in nanowells has been performed [6] as
well as indirect detection of enzymatic activity by mechan-
ism-based suicide inhibitors [7]. In order to maintain
unbound reaction products on the spot of reaction, Gosalia
and co-workers [8] spotted chemical compounds in nanoliter
droplets on flat surfaces and applied the enzyme solution on
top by aerosol deposition. Schweitzer and colleagues [9, 10]
described a new methodology named Rolling Circle Ampli-
fication for signal amplification on microarrays, which relies
on enzymatic extension of an primer-antibody conjugate fol-
lowed by hybridization of labeled probes to the generated
DNA strand. As an alternative approach to fluorescent
detection, Huang and colleagues [29] applied chemilumi-
nescence for the sensitive detection of multiple cytokines.
However, all currently presented solutions either lack the
possibility of multiplex screening of analytes against
enzymes, or require complicated liquid handling, surface
modifications, and additional equipment.
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2 Material and methods
Polystyrene cell culture slides were purchased from Nalge
Nunc (Rochester, NY, USA) and Amplex Red Hydrogen
Peroxide/Peroxidase Assay Kit, BODIPY TR casein as part of
the EnzChek Protease Assay Kit (red fluorescence), 9H-
(1,3-dichloro-9,9-dimethylacridin-2-one-7-yl) phosphate as
well as phenylethyl-b-D-thiogalactopyranoside were pur-
chased from Molecular Probes (Leiden, The Netherlands).
Alkaline phosphatase (AP) and resofurin b-D-galactopyrano-
side were obtained from Sigma-Aldrich (Munich, Germany),
b-galactosidase from Fluka (Buchs, Switzerland) and bovine
kidney cathepsin D was obtained from Calbiochem (San
Diego, CA, USA).
2.1 Assay of inhibition for horseradish peroxidase
All components of this assay with the exception of the sodium
azide and the polystyrene cell culture slides were part of the
Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit.
Stock solutions (10 mM) of the fluorogenic substrate 10-acetyl-
3,7-dihydroxyphenoxazine were prepared as described by the
manufacturer. The stock solution was diluted down to 100 mM
using 1x reaction buffer and spotted onto polystyrene cell
culture slides using a QArray spotting robot (Genetix, New
Milton, Hampshire, UK) equipped with 16 6 150 mm solid
steel pins. Horseradish peroxidase (HRP) and H2O2 stock
solutions were diluted as described by the manufacturer and
two aliquots of enzyme solution containing 0.2 U/mL HRP in
20 mM H2O2 and 8.7% v/v glycerol diluted in 1x reaction buf-
fer were generated, one with and one without 1% w/v sodium
azide. Both aliquots were spotted at room temperature in sets
of 32 spots per aliquot onto the fluorogenic substrate and on a
part of the slide without substrate. The slides were scanned
directly after spotting using a ScanArray 4000 scanner (Perkin
Elmer, Wellesley, MA, USA). After scanning, the slides were
placed in a dark, humidified chamber and incubated at 377C
for 2 h. The slideswere scanned again using the same settings
and analyzed using the GenePix Pro 4.1 software (Axon
Instruments, Union City, CA, USA).
2.2 Determination of the detection limit for
horseradish peroxidase
The determination of the detection limits was performed as in
the assay of inhibition described in a Section 2.1 with the fol-
lowing exceptions: The fluorogenic substrate was dissolved to
a concentration of 10 mM in double-distilled (dd) H2O. Dilu-
tion steps of HRP ranging from 16 755 to 0 molecules per spot
were prepared in 20 mM H2O2 and 8.7% v/v glycerol diluted in
1x reaction buffer and spotted in sets of 64 replicates per con-
centration step. Scanning was performed with the same
scanner settings directly after spotting and after a 2.5 h incu-
bation in a dark, humidified chamber at 377C. The mean sig-
nal intensity of each concentration was calculated and the
detection limit (mean + 2 SD) was determined.
2.3 Assay of inhibition for alkaline phosphatase
The fluorogenic substrate 9H-(1,3-dichloro-9,9-dimethylacri-
din-2-one-7-yl) phosphate (DDAO phosphate) was diluted to a
concentration of 5 mM using ddH2O and spotted as described
in Section 2.2. In a second spotting step, different concentra-
tions ranging from 10mM to 1 mM EDTA dissolved in ddH2O
as well as ddH2O alone were spotted in sets of 16 spots onto
the immobilized substrate. Enzyme solution was prepared at
a concentration of 981 mU/mL alkaline phosphatase (AP) in
AP buffer (1 mM MgCl2, 100 mM Tris-HCl, pH 9.5) containing
8.7% v/v glycerol and spotted in sets of 16 spots onto the
positions of the substrate/EDTA. Scanning analysis was per-
formed directly after spotting as described in Section 2.1.
2.4 Determination of the detection limits for alkaline
phosphatase
For the detection limit assay, the fluorogenic substrate
DDAO phosphate was spotted at a concentration of 5 mM. In
a second spotting step, different amounts of AP ranging
from 9433 to 0 molecules per spot were prepared in AP buffer
containing 8.7% v/v glycerol and spotted in sets of 64 spots
per concentration step onto the immobilized DDAO phos-
phate. Scanning was performed with the same scanner set-
tings directly after spotting and after a 2 h incubation in a
dark, humidified chamber at 377C. The mean signal inten-
sity of each concentration was calculated and the detection
limit (mean + 2 SD) was determined.
2.5 Assay of inhibition for -galactosidase
A stock solution of the fluorogenic substrate resorufin b-D-
galactopyranoside was prepared with a concentration of
20mg/mL using DMSO. Working dilutions of 0.2 mg/mL
were prepared and spotted as described in Section 2.3. Dilu-
tions of 2-phenylethyl b-D-thiogalactoside (PETG) were pre-
pared ranging from 3.3 mM to 0.33 mM in ddH2O and spotted
in sets of 16 spot per concentration step onto the substrate. In
a third spotting step, a b-gal dilution of 1 U/mL was prepared
in PBS containing 8.7% v/v glycerol and spotted in sets of 16
spots per concentration step. Scanning and analysis was per-
formed directly after spotting.
2.6 Determination of the detection limits for
-galactosidase
The determination of the detection limits was carried out as
in the assay of inhibition with the following exceptions: b-gal
dilutions ranging from 42.57 to 0 amol per spot were pre-
pared in PBS containing 8.7% v/v glycerol and spotted in
sets of 64 spots per concentration step onto the fluorogenic
substrate. Scanning was performed with the same scanner
settings directly after spotting and after a 2 h incubation in a
dark, humidified chamber at 377C. The mean signal inten-
sity of each concentration was calculated and the detection
limit (mean + 2 SD) was determined.
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2.7 Determination of thedetection limit for cathepsinD
For the determination of the detection limit, a 1 mg/mL
stock solution of BODIPY TR casein was prepared by addi-
tion of 200 mL sodium citrate buffer (pH 3.5). Stock solution
was dissolved down to 20 mg/mL BODIPY TR casein using
20 mM sodium citrate (pH 3.5) containing 8.7% v/v glycerol
as buffer and spotted as described in Section 2.1. Dilution
steps ranging from 4013 to 0 amol per spot were prepared
using 20mM sodium citrate (pH 3.5) containing 8.7% v/v
glycerol and spotted as described previously. Scanning was
performed directly and after a 1 h incubation at 377Cwith the
same scanning settings.
3 Results and discussion
To demonstrate the principle of multiplex enzymatic assays
in subnanoliter volumes on a microarray, different enzymes
such as alkaline phosphatase or horseradish peroxidase were
tested. The principle of the assays is based on the multiple
spotting technology (MIST) [11, 12] and comprises two spot-
ting steps in which the fluorogenic substrates are spotted in a
first round of spotting, followed by the transfer of enzyme
solution in a second round of spotting. Since the enzyme
solution contains hygroscopic additives, such as glycerol, the
total evaporation of the transferred solution, which is initially
about 0.6 nL [13], is prevented.
One crucial issue for such assays was the choice of an
appropriate surface, which should provide a favorable envi-
ronment for the reaction. In this case, interaction with the
surface was considered detrimental for enzymatic reactions,
as it was determined that immobilization can compromise
functionality of proteins [14]. Three different surfaces were
tested, which comprised poly-L-lysine coated slides, BSA
coated epoxy slides and polystyrene slides. As all three sur-
faces proved their applicability for enzymatic assays (data not
shown), polystyrene slides were used in all further experi-
ments, being inexpensive and displaying a low binding ca-
pacity as determined in previous studies [15, 16].
3.1 Horseradish peroxidase
The first enzyme tested was HRP, which is one of the most
commonly used enzymes for ELISA and catalyzes the oxida-
tion of its substrate by transfer of an oxygen from a donor
such as hydrogen peroxide to the substrate. Activity can be
inhibited by the addition of sodium azide, which leads to the
production of the inactivating azidyl radical [17]. To demon-
strate the activity of HRP, an inhibition assay using sodium
azide as a specific inhibitor was performed (Fig. 1). To display
the time dependence of the enzymatic action, the microarray
was scanned directly after spotting (designated as 0 h) and
after a 2 h incubation at 377C. To show the sensitivity of the
reaction, a dilution row of HRP was prepared and spotted in a
second spotting step onto the previously deposited fluoro-
genic substrate. The scanning was performed directly after
spotting (0 h) and after 2.5 h incubation at 377C (Fig. 2).
Figure 1 clearly demonstrates that the increase of signal
intensity is dependent on enzymatic activity. While nearly no
signals arise in the inhibited reaction, medium intensity signals
can be seen in the uninhibited reaction without incubation,
which increase upon incubation at 377C. Negative controls lack-
ing the enzyme, which were performed on the same chip, dis-
played signal intensities that were indistinguishable from back-
ground (data not shown). Figure 2 does not display any signal
intensities for the dilution row without incubation time, while
increasing signal intensities with increasing enzyme concentra-
tion can be seen after 2.5 h incubation with a total detection limit
of 0.85 zmol (,510 molecules HRP) per spot.
Figure 1. Scans of inhibition assay for HRP and quantification. Left: Two assays were performed using 0.2mU/mL HRP, one without and
one with 1% w/v NaN3. Scanning and analysis was performed without incubation and after 2 h incubation. Right: Mean signal intensity
versus time of incubation diagram with standard deviation error bars for inhibition assay of HRP. Two measurements of the same chip were
performed, one directly after spotting, indicated by 0 h and one after 2.5 h of incubation.
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Figure 2. Detection limit assay for HRP. Mean signal intensity
versus activity of HRP diagram with standard deviation error bars
for the detection limit assay of HRP. A dilution row ranging from
27.8 to 0 molecules HRP per spot was prepared and spotted onto
a fluorogenic substrate. Scanning and analysis were performed
without incubation and after 2.5 h incubation.
3.2 Alkaline phosphatase and -galactosidase
Similar assays to demonstrate the applicability of the multi-
ple spotting technique to enzymes were performed using
alkaline phosphatase (AP) and b-galactosidase (b-gal). In
contrast to HRP, both enzymes display different activities,
with AP catalyzing dephosphorylation and b-gal catalyzing
transgalactosidation. Enzymatic function of AP is hereby
mainly regulated by divalent cations as essential activators.
Addition of EDTA, which is a well-known chelator of divalent
cations, results in complete and irreversible functional block
of all AP activity [17]. b-Gal catalyzes the hydrolysis of termi-
nal, nonreducing b-D-galactose residues in b-D-galactosides.
PETG is a nonhydrolyzable analog of the b-D-galactose and is
commonly used as a selective and reversible inhibitor of b-
gal [6, 19–21]. To demonstrate the functionality of both
enzymes, AP and b-gal were subjected to assays of inhibition
(Figs. 3 and 5). Moreover, dilution row assays were per-
formed for determination of the detection limits of both
enzymes with and without incubation (Figs. 4 and 6).
Figure 3 displays decreasing signal intensity with
increasing EDTA concentrations, which proves functionality
of AP on the microarray. The determination of the detection
Figure 3. Assay of inhibition for AP. Mean signal intensity versus
concentration of EDTA diagram with standard deviation error
bars for inhibition assay of AP. A dilution row of EDTA was pre-
pared ranging from 10mM to 0 mM EDTA and applied to a micro-
array based assay of AP. Scanning and analysis were performed
without incubation.
Figure 4. Detection limit assay for AP. Mean signal intensity ver-
sus activity of AP diagram with standard deviation error bars for
the detection limit assay of AP. A dilution row ranging from 15.6
to 0 molecules AP per spot was prepared and spotted onto a
fluorogenic substrate. Scanning and analysis were performed
without incubation and after 2 h incubation.
limit without incubation (Fig. 4) only shows minor signal
intensities on the microarray. However, after incubation of
the microarray for 2 h, strong signal intensities can be
observed with a saturation of the signal with increasing en-
zyme concentration, clearly demonstrating enzyme activity.
Quantification of the detection limit revealed 5 zmol (,3000
molecules AP) without incubation and 0.06 zmol (,35
molecules AP) after a 2 h incubation.
The assay of inhibition for b-gal is shown in Fig. 5. As
anticipated, it displays decreasing signal intensities with
increasing inhibitor concentration. The same holds true for
the dilution row assay, which displayed increasing signal
intensities with increasing enzyme concentration (Fig. 6).
3.3 Cathepsin D
To apply the multiple spotting technique to more sensitive
enzymes with medicinal relevance, we have also tested ca-
thepsin D on microarrays. Cathepsin D is an acid protease,
belonging to the peptidase family A1. It is suggested to play a
role in the pathogenesis of sporadic Alzheimer’s disease [22]
and in the process of tumor invasion and metastasis of dif-
Figure 5. Assay of inhibition for b-gal. Mean signal intensity ver-
sus concentration of PETG diagram with standard deviation error
bars for inhibition assay of b-gal. A dilution row of PETG was
prepared ranging from 3.3mM to 0.33 mM PETG and applied to a
microarray-based assay of b-gal. Scanning and analysis were
performed without incubation.
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Figure 6. Detection limit assay for b-gal. Mean signal intensity
versus activity of b-gal diagram with standard deviation error
bars for the detection limit assay of b-gal. A dilution row ranging
from 42.57 to 0 amol per spot b-gal was prepared and spotted
onto a fluorogenic substrate. Scanning and analysis were per-
formed without incubation and after 2 h incubation.
ferent types of cancer [23, 24]. Moreover, the measurement of
cathepsin D activity can serve as a prognostic marker in
breast cancer [25].
Using the multiple spotting technique, we were able to
measure decreasing signal intensities with decreasing en-
zyme concentration (Fig. 7). An increase of signal intensity
after incubation could be observed, which shifted the detec-
tion limit from 648 amol/spot without incubation to 464
amol/spot after an 1 h incubation. These results display a
10 to 15-fold decrease of detection limit of the microarray-
based approach in comparison to the microtiter plate [26].
Reasons for this decrease may be the superior sensitivity of
the scanner or the limited diffusion possibility of the fluoro-
genic substrate, which enhanced the frequency of substrate-
enzyme interaction and hence promoted catalysis. However,
since casein is not the optimal substrate of cathepsin D and
was used due to hardware limitations, it can be expected that
even better results can be obtained using an optimized
fluorogenic substrate.
3.4 Outlook
Although unprecedented detection limits have been
observed, an optimization of the methodology according to
enzyme and substrate may allow even lower detection limits.
An important point to consider in this context is the sub-
strate concentration, which is a limiting factor in the experi-
ments shown above and may have influenced the results by
end-product inhibition. Furthermore, the use of optimized
buffers or hygroscopic substance other than glycerol may
enhance detection and hence provide better sensitivity.
Another factor is the transfer of the compounds to the chip
surface. While contact printing systems provide reliable
deposition of compounds with varying properties, non-contact
printing systems may be more adequate in some applications,
since they provide more gentle handling of the substance to be
spotted and especially for the substances onto which is depos-
ited. As the microarray surface is not required for the immobi-
lization of the enzymes, it is conceivable that other surfaces
Figure 7. Detection limit assay for cathepsin D. Mean signal
intensity versus activity of cathepsin D diagram with standard
deviation error bars for the detection limit assay of cathepsin D. A
dilution row ranging from 4013 to 0 amol cathepsin D per spot
was prepared and spotted onto a fluorogenic substrate. Scan-
ning and analysis were performed without incubation and after
1 h incubation.
such as matrices used for mass spectrometry can be applied
as well. This would allow the readout of enzymatic reactions
for which fluorescence-based assays are not available. Since
the product is known, it can be used for calibration, thus
facilitating the detection in a highly parallel fashion.
Areas of application for the enzymatic assay on the chip
include the characterization of enzymes with regard to sub-
strate specificity or activity. This approach is especially useful
in metagenomics, which is currently seeking new enzymes
with novel functionalities [27, 28]. In addition, assays can be
performed on a large scale to screen for potent inhibitors or
new substrates. Another valuable application is the amplifi-
cation of enzymatic reactions using enzyme-antibody con-
jugates. Since the development of an amplification method
for proteins comparable to PCR is not in sight, the screening
of complex protein samples on microarrays requires a very
sensitive detection procedure current microarray technolo-
gies cannot deliver. An enzymatic amplification of the signal
as commonly applied in ELISA would therefore be desirable.
Apart from fluorescent detection, chemiluminescent detec-
tion may be beneficial in some applications, which suffer
from high background fluorescence. This approach could be
especially beneficial in drug and disease screening assays
and the optimization screening of enzyme mutants for bio-
technology, both areas in which high-throughput is required.
4 Concluding remarks
Taken together, alkaline phosphatase, horseradish perox-
idase and b-galactosidase were tested on a microarray with
regard to inhibition of enzymatic action and determination
of the detection limit. All three enzymes catalyze different
reactions, such as oxidation, dephosphorylation and trans-
galactosidation and showed specific inhibition using the re-
spective inhibitors. While displaying comparable detection
limits with regard to activity, an unprecedented shift of sen-
sitivity was observed with a limit of down to 0.06 zmol
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(,35molecules) per spot. To anticipate further areas of
application with more sensitive enzymes of medicinal rele-
vance, cathepsin D was tested and a 10 to 15-fold more sen-
sitive detection was observed using a suboptimal substrate.
We have shown that enzymatic assays can be transferred to
the microarray format by application of our MIST approach.
Finally, we have demonstrated that the approach allows the
detection of minute amounts of enzymatic activities using
only standard microarray equipment.
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